Cytonics Corporation is a biotechnology research and development company based in Jupiter, FL. They specialize in developing diagnostics and therapeutics for osteoarthritis, with their flagship product being the Fibronectin-Aggrecan Complex Test (FACT) that can detect cartilage damage due to osteoarthritis. Cytonics has also developed an autologous therapy called APIC, based on the function of the naturally-occurring blood protein Alpha-2 Macroglobulin (A2M), which protects cartilage from degradation and alleviates joint pain. With a mission to rid the world of the pain and suffering caused by osteoarthritis, Cytonics is a leader in the field of regenerative medicine and is focused on developing innovative biologic therapies for this condition. Supported by hundreds of physicians nationwide, Cytonics has licensed their FACT diagnostic to Synthes (acquired by Johnson & Johnson) and has sold their APIC therapy directly to physicians through a national medical device distributor. They have treated over 6,000 patients to date, ranging from the elderly to young athletes. Cytonics is also actively developing new A2M-based therapies with the goal of out-licensing to strategic partners at critical clinical value inflection points. With their breakthrough technology and commitment to improving the quality of life for osteoarthritis patients, Cytonics is positioned to disrupt the field of regenerative medicine.Generated from the website

Cicalese, Patrick Aty

Stone Henge Insurance Solutions

KMJ South Florida LLC

FedEx Drop Box